Jaundice, Neonatal Completed Phase 2 Trials for Stannsoporfin (DB04912)

Also known as: Neonatal Jaundice / Jaundice Neonatal / Arias syndrome / Icterus neonatorum / Jaundice of newborn / Jaundice in baby / Neonatal physiological jaundice (intense)(prolonged) NOS

IndicationStatusPhase
DBCOND0031494 (Jaundice, Neonatal)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01887327Study Evaluating the Safety and Efficacy of Two Doses of Stannsoporfin in Combination With Phototherapy in Neonates With HyperbilirubinemiaTreatment